If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.554    -0.004 (-0.72%)
Bid:
0.45
Ask:
0.50
Spread: 0.05 (11.111%)
Market Cap: £3.22m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Major Interest in Shares

23 Jun 2010 13:56

RNS Number : 1261O
Futura Medical PLC
23 June 2010
 



For immediate release

23 June 2010

 

Futura Medical plc

("Futura" or "the Group" or "the Company")

 

TR-1: Notification of major interests in shares

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

Futura Medical plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

Brookwell Limited

4. Full name of shareholder(s)  (if different from 3.):

Nortrust Nominees Limited

 

5. Date of the transaction and date on which the threshold is crossed or reached:

 

22 June 2010

6. Date on which issuer notified:

23 June 2010

7. Threshold(s) that is/are crossed or reached:

 

3%

 

8. Notified details:

 

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary Shares

GB0033278473

2,128,835

2,128,835

1,778,835

Below 3%

Below 3%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

 

Expiration date

 

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

 

% of voting rights

None

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

 

 

Exercise price

 

Expiration date

 

Exercise/ Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 

None

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

1,778,835

 

Below 3%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

None

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Progressive AIM Realisation Limited is Investment Manager to Brookwell Limited.

 

14. Contact name:

Russell Scott

15. Contact telephone number:

020 7490 4355

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLKKNDPBBKDPAB
Date   Source Headline
30th Jun 20265:02 pmRNSHolding(s) in Company
30th Jun 20267:00 amRNSHighly positive data from WSD4000 studies
29th Jun 20262:17 pmRNSCorrection: Result of AGM
29th Jun 20261:14 pmRNSResult of AGM
29th Jun 20267:00 amRNSNew US commercial partner
4th Jun 20267:00 amRNSNotice of AGM & availability of Annual Report
1st Jun 20263:30 pmRNSBlock Listing Six Monthly Return
22nd May 202612:06 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSUnaudited Results for the Year Ended 31 Dec 2025
20th Apr 20267:00 amRNSNotice of Results & Investor Presentation
23rd Mar 20267:00 amRNSPositive Eroxon® & Eroxon® “Intense” HUT results
18th Mar 20267:00 amRNSFormal Grant of US Patent
17th Mar 202611:37 amRNSHolding(s) in Company
20th Feb 20264:06 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSPatent notice of allowance granted for the US
4th Feb 20267:00 amRNSTrading Update
13th Jan 202612:53 pmRNSHolding(s) in Company
13th Jan 202612:51 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSResults of WSD4000 Early Feasibility Study
7th Jan 20264:34 pmRNSNotification of major holdings
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
30th Dec 20255:31 pmRNSNotification of major holdings
30th Dec 20255:31 pmRNSNotification of major holdings
23rd Dec 20254:37 pmRNSNotification of major holdings
23rd Dec 20254:37 pmRNSNotification of major holdings
18th Dec 20256:15 pmRNSNotification of major holdings
18th Dec 20256:15 pmRNSNotification of major holdings
18th Dec 20255:41 pmRNSNotification of major holdings
18th Dec 20255:41 pmRNSNotification of major holdings
12th Dec 20254:18 pmRNSNotification of major holdings
10th Dec 202512:01 pmRNSNotification of major holdings
10th Dec 202512:00 pmRNSNotification of major holdings
10th Dec 20257:00 amRNSPatent notice of allowance granted for China
9th Dec 20253:59 pmRNSBlock Listing Six Monthly Return
8th Dec 20251:34 pmRNSNotification of major holdings
8th Dec 202512:18 pmRNSDirectors' / PDMR dealing
4th Dec 20253:43 pmRNSNotification of major holdings
4th Dec 20253:41 pmRNSNotification of major holdings
3rd Dec 20257:00 amRNSBoard change
2nd Dec 202511:27 amRNSResult of General Meeting and Total Voting Rights
14th Nov 20254:40 pmRNSPCA Dealing
13th Nov 20254:35 pmRNSPosting of Circular and Notice of GM
13th Nov 20257:00 amRNSFundraise of £2.75 million
3rd Nov 202511:04 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSResults for the six months ended 30 June 2025
26th Sep 202512:11 pmRNSNotice of Results and Investor Presentation
19th Sep 20257:00 amRNSTrading, Business and Strategic Review Update
29th Aug 20257:00 amRNSTotal Voting Rights
8th Aug 20257:00 amRNSBoard Changes, Business Update & Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.